What is the cutoff for Fractional exhaled Nitric Oxide (FeNO) to diagnose asthma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

FeNO Cut-off Values for Asthma Diagnosis

For adults, a FeNO value >50 ppb indicates eosinophilic airway inflammation and likely asthma, while <25 ppb makes eosinophilic inflammation and asthma unlikely. For children, the cut-off values are >35 ppb and <20 ppb, respectively. 1

FeNO Cut-off Values by Age Group

Adults:

  • Low FeNO: <25 ppb - Eosinophilic airway inflammation unlikely
  • Intermediate FeNO: 25-50 ppb - Interpret with caution
  • High FeNO: >50 ppb - Eosinophilic airway inflammation present

Children:

  • Low FeNO: <20 ppb - Eosinophilic airway inflammation unlikely
  • Intermediate FeNO: 20-35 ppb - Interpret with caution
  • High FeNO: >35 ppb - Eosinophilic airway inflammation present

Clinical Significance of FeNO Values

High FeNO (>50 ppb in adults, >35 ppb in children):

  • Strongly indicates presence of eosinophilic airway inflammation 1, 2
  • Predicts likely responsiveness to inhaled corticosteroid (ICS) therapy 1
  • Associated with increased risk of asthma exacerbations 2, 3
  • Has a positive predictive value of 77% for sputum eosinophilia ≥3% 4

Low FeNO (<25 ppb in adults, <20 ppb in children):

  • Eosinophilic airway inflammation unlikely 1
  • Alternative diagnoses should be considered 1
  • Negative predictive value of 88% for ruling out sputum eosinophilia 4
  • Patient unlikely to benefit from ICS therapy 1

Intermediate FeNO (25-50 ppb in adults, 20-35 ppb in children):

  • Interpret with caution and in clinical context 1
  • Monitor changes in FeNO over time 1
  • May indicate atopic asthma, eosinophilic bronchitis, or COPD with mixed inflammatory phenotype 1

Interpreting FeNO in Clinical Practice

Diagnostic Value:

  • FeNO >50 ppb has high specificity but moderate sensitivity (37%) for detecting eosinophilic inflammation 4
  • FeNO should not be used as the sole diagnostic criterion for asthma 2
  • Combining FeNO with other clinical assessments (like Asthma Control Test) significantly improves diagnostic accuracy 5

Monitoring Value:

  • Persistent elevation of FeNO ≥50 ppb over time is associated with higher exacerbation risk 3
  • High variability in FeNO measurements over time also predicts exacerbations 3
  • A significant response to anti-inflammatory therapy is indicated by:
    • A reduction of at least 20% in FeNO for values over 50 ppb
    • A reduction of more than 10 ppb for values lower than 50 ppb 1

Important Considerations and Pitfalls

Confounding Factors:

  • Age, height, sex, and atopy status can affect FeNO levels 1
  • Smoking reduces FeNO levels, potentially leading to false-negative results 1
  • Recent respiratory infections can temporarily increase FeNO 2

Clinical Pitfalls:

  • Not all asthma is associated with high FeNO (e.g., non-eosinophilic/neutrophilic asthma) 2
  • Overreliance on absolute FeNO values without considering clinical context 2
  • Intermediate FeNO values (25-50 ppb) are common in real-life populations, which may limit clinical usefulness 4
  • FeNO should be interpreted alongside clinical symptoms and lung function tests, not in isolation 1, 2

By understanding these cut-off values and their clinical significance, clinicians can better utilize FeNO measurements to diagnose asthma, predict steroid responsiveness, and monitor treatment efficacy.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.